
Bildnachweis: TVM/Jacobian.
The global healthcare sector is under increasing pressure to improve efficiency, and radiology faces particular challenges. The volume of imaging data requiring interpretation is growing exponentially, while the number of specialists is stagnating at critical levels. Against this backdrop, Jacobian™ was created through the acquisition of the industry-leading US platform Fluency for Imaging from Solventum (formerly 3M) by the Munich-based healthtech company Smart Reporting. This merger unites two complementary technology platforms to create an integrated solution for diagnostic imaging– with implications for radiologists, clinical research, and investors.
The newly formed entity boasts a unique history: originally founded in Munich in 2014 as Smart Reporting by radiologist Prof. Dr. med. Wieland Sommer, the company was founded with the vision of improving clinical workflows through structured and data-driven reporting. Recently, Sommer achieved a major M&A milestone: the Munich-based enterprise acquired the US market leader Fluency for Imaging and has since been operating as Jacobian. “Diagnostic imaging is in a state of transformation, from standalone reporting to enterprise imaging where the system must handle not only more complex workflows but also more complex integrations. And we realised that efficiency cannot come at the expense of quality. So how do we bring transformation without destabilising the current reporting environment? For that we needed a platform that was already battle-tested, already client trusted, to which we could bring next-gen innovation so that it’s also tomorrow ready. Innovation without disruption that was the guiding light behind the merger of two leaders that have since mutually amplified the other’s strengths”, said Sommer, who is also one of the Strüngmann Award finalists.
The USP: Seamless ‘Ambient Reporting’
Radiological software has long been characterised by fragmented systems. Many hospitals still rely on conventional dictation software, which turns free-text reports into a dead end in the data flow: the information is neither machine-readable nor easy to analyse, contributing to diagnostic variability. Meanwhile, start-ups offering standalone AI image analysis tools often struggle to integrate their solutions into existing hospital IT workflows. Jacobian addresses this fragmentation with a seamless end-to-end platform combining two complementary technologies. Jacobian Fluency for Imaging is the market-leading conversational AI platform, named Best in KLAS, a healthcare IT insights and research company, for Speech Recognition, Front-End Imaging for five consecutive years, from 2022 to 2026. Smart Reporting complements this with AI-driven structuring, translating physicians’ spoken words in real time into standardised, guideline-compliant and, crucially, machine-readable clinical data. By understanding the radiological context, the AI helps reduce physicians’ administrative burden and improve workflow efficiency. Beyond integrating existing systems and structuring clinical data, Jacobian aims to bring the entire radiological workflow together through agentic AI. As Sommer explains: “We see the Jacobian agentic AI platform as the control plane, connecting systems, workflows, findings, AI inputs and more. And the radiologist is at the centre, always in control – our mission is to amplify their best work. Ambient intelligence is part of the core Jacobian experience. It’s not just about automation – that’s the easy part. It’s about synthesising and contextualising information from various systems and stages of the workflow into a coherent, personalised report that reads like I wrote it and one that I can stand behind with clinical confidence. That’s the difference.”
Global Scaling and Market Power
Headquartered in Munich and Pittsburgh, USA, Jacobian serves more than 10,000 radiologists worldwide and processes over 80 million reports annually. Its combination of complementary, market-leading technologies has created a globally scalable platform with proven market traction. Lead investor TVM Capital Life Science sees the company as an example of how European healthtech businesses can build a global presence. “From an investor’s perspective, the decisive factors are strategic fit and value creation in the relevant markets – in Jacobian’s case that´s the USA as it is for many technologies,” says Dr. Hubert Birner, Managing Partner at TVM Capital Life Science. “By bringing together two companies with complementary, market-leading technologies, we have created a differentiated and globally scalable platform with proven market traction.” Birner sees Jacobian’s potential extending beyond its current market position: “Jacobian’s products have deep clinical relevance and the potential to improve both radiologists’ efficiency and the quality of patient care worldwide. This is exactly the kind of global healthtech champion that TVM aspires to build and scale. At the same time, Jacobian demonstrates that European companies can become global leaders when they have access to the late-stage capital required to execute near-term growth strategies and compete internationally.”
Company Factsheet
• Name: Jacobian™
• Sector: Healthtech / AI-driven Diagnostics
• Number of Employees: >150 [Please insert current number, e.g. > 200]
• Investors: TVM Capital Life Science, Bayern Kapital (Series C Smart Reporting)
• Website: www.jacobian.com


